10:00

Introductory remarks

Greetings

Mikhail Alexandrovich Piradov
Vladimir Ivanovich Starodubov

Vladimir Pavlovich Chekhonin
Valery Vasilievich Beregovykh

10:15

Risk Factors and Principles of Thrombosis Treatment

Cihan Ay

10:45

Catastrophic Forms of Thrombosis in Clinical Practice

Alexander Davidovich Makatsaria

11:10

Personification of Antithrombotic Therapy in the Time of Clinical Guidelines

Nikita Valerievich Lomakin

11:35

Antiphospholipid Syndrome: Facts and Controversies

Gris Jean-Christophe Raymond

11:50

Catastrophic Antiphospholipid Syndrome

Victoria Omarovna Bitsadze

12:25

Are there Sex-Related Differences in Platelet Aggregation and Response to Antiplatelet Drugs?

Marco Cattaneo

12:35

Prevention and Treatment of Cancer-Associated Thrombosis in the Time of Targeted Anticancer Therapy

Grigoris Gerotsiafas

13:10

Break

13:30

Cerebrovascular Diseases and Hemostasis

Marine Movsesovna Tanashyan

13:50

Primary Thromboprophylaxis in Patients with Cancer: Problems of Multiple Risks

Ismail Elalami

14:10

Pharmacogenetics of Antithrombotic Therapy: What’s New?

Dmitry Alekseevich Sychev

14:35

Acetylsalicylic acid in primary prevention of CVD: who and when?

Zhanna Davidovna Kobalava

15:00

NOACs in Stroke Prevention in Atrial Fibrillation: From Risk to Victory

Philip Nikolaevich Paleev

15:20

News in Antithrombotic Therapy after Transcatheter Interventions on the Aortic and Atrioventricular Valves

Olga Leonidovna Barbarash

15:45

Discussion of the conclusions of the conference